Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Bunchai Chongmelaxme, Maythika Hammanee, Wariya Phooaphirak, Surachai Kotirum, Raymond Hutubessy & Nathorn Chaiyakunapruk. (2017) Economic evaluations of Haemophilus influenzae type b (Hib) vaccine: a systematic review. Journal of Medical Economics 20:10, pages 1094-1106.
Read now
Read now
Phuc Le, Van T. Nghiem & J. Michael Swint. (2016) Post-GAVI sustainability of the Haemophilus influenzae type b vaccine program: The potential role of economic evaluation. Human Vaccines & Immunotherapeutics 12:9, pages 2403-2405.
Read now
Read now
Articles from other publishers (21)
Mélanie Drolet, Élodie Bénard, Mark Jit, Raymond Hutubessy & Marc Brisson. (2018) Model Comparisons of the Effectiveness and Cost-Effectiveness of Vaccination: A Systematic Review of the Literature. Value in Health 21:10, pages 1250-1258.
Crossref
Crossref
Surachai Kotirum, Charung Muangchana, Sirirat Techathawat, Piyameth Dilokthornsakul, David Bin-Chia Wu & Nathorn Chaiyakunapruk. (2017) Economic Evaluation and Budget Impact Analysis of Vaccination against Haemophilus influenzae Type b Infection in Thailand. Frontiers in Public Health 5.
Crossref
Crossref
Kittiphong Thiboonboon, Benjarin Santatiwongchai, Varit Chantarastapornchit, Waranya Rattanavipapong & Yot Teerawattananon. (2016) A Systematic Review of Economic Evaluation Methodologies Between Resource-Limited and Resource-Rich Countries: A Case of Rotavirus Vaccines. Applied Health Economics and Health Policy 14:6, pages 659-672.
Crossref
Crossref
Y. Natalia Alfonso, Guiru Ding & David Bishai. (2016) Income Elasticity of Vaccines Spending versus General Healthcare Spending. Health Economics 25:7, pages 860-872.
Crossref
Crossref
Mark Jit & Raymond Hutubessy. (2016) Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible?. Applied Health Economics and Health Policy 14:3, pages 245-252.
Crossref
Crossref
Ulla Kou Griffiths, Rosa Legood & Catherine Pitt. (2016) Comparison of Economic Evaluation Methods Across Low-income, Middle-income and High-income Countries: What are the Differences and Why?. Health Economics 25, pages 29-41.
Crossref
Crossref
Catherine Pitt, Catherine Goodman & Kara Hanson. (2016) Economic Evaluation in Global Perspective: A Bibliometric Analysis of the Recent Literature. Health Economics 25, pages 9-28.
Crossref
Crossref
Mark Jit & Walter Mibei. (2015) Discounting in the evaluation of the cost-effectiveness of a vaccination programme: A critical review. Vaccine 33:32, pages 3788-3794.
Crossref
Crossref
Cyril Nogier, Patrick Hanlon, Karin Wiedenmayer & Nicolas Maire. (2015) Can a Compact Pre-Filled Auto-Disable Injection System (cPAD) Save Costs for DTP-HepB-Hib Vaccine as Compared with Single-Dose (SDV) and Multi-Dose Vials (MDV)? Evidence from Cambodia, Ghana, and Peru. Drugs - Real World Outcomes 2:1, pages 43-52.
Crossref
Crossref
Maria-Florencia Hutter, Roberto Rodríguez-Ibeas & Fernando Antonanzas. (2013) Methodological reviews of economic evaluations in health care: what do they target?. The European Journal of Health Economics 15:8, pages 829-840.
Crossref
Crossref
Diana C. Otczyk & Allan W. Cripps. (2013) Delivering vaccines for the prevention of pneumonia — programmatic and financial issues. Pneumonia 2:1, pages 16-25.
Crossref
Crossref
Ulla Kou Griffiths, Andrew Clark & Rana Hajjeh. (2013) Cost-Effectiveness of Haemophilus influenzae Type b Conjugate Vaccine in Low- and Middle-Income Countries: Regional Analysis and Assessment of Major Determinants. The Journal of Pediatrics 163:1, pages S50-S59.e9.
Crossref
Crossref
A. H. Miners. (2012) Economic evaluations of prophylaxis with clotting factor for people with severe haemophilia: why do the results vary so much?. Haemophilia 19:2, pages 174-180.
Crossref
Crossref
Ulla K. Griffiths, Yakou Dieye, Jessica Fleming, Rana Hajjeh & Karen Edmond. (2012) Costs of Meningitis Sequelae in Children in Dakar, Senegal. Pediatric Infectious Disease Journal 31:11, pages e189-e195.
Crossref
Crossref
U. K. GRIFFITHS, A. CLARK, B. GESSNER, A. MINERS, C. SANDERSON, E. R. SEDYANINGSIH & K. E. MULHOLLAND. (2012)
Dose-specific efficacy of
Haemophilus influenzae
type b conjugate vaccines: a systematic review and meta-analysis of controlled clinical trials
. Epidemiology and Infection 140:8, pages 1343-1355.
Crossref
Crossref
M. Makinen, M. Kaddar, V. Molldrem & L. Wilson. (2012) New vaccine adoption in lower-middle-income countries. Health Policy and Planning 27:suppl 2, pages ii39-ii49.
Crossref
Crossref
Rana Hajjeh. (2011)
Accelerating introduction of new vaccines: barriers to introduction and lessons learned from the recent
Haemophilus influenzae
type b vaccine experience
. Philosophical Transactions of the Royal Society B: Biological Sciences 366:1579, pages 2827-2832.
Crossref
Crossref
Ulla K. Griffiths, Andrew Clark, Veronika Shimanovich, Irina Glinskaya, Dilorom Tursunova, Lucia Kim, Liudmila Mosina, Rana Hajjeh & Karen Edmond. (2011) Comparative Economic Evaluation of Haemophilus influenzae Type b Vaccination in Belarus and Uzbekistan. PLoS ONE 6:6, pages e21472.
Crossref
Crossref
Sachiko OzawaMeghan L. StackDavid M. BishaiAndrew MirelmanIngrid K. FribergLouis NiessenDamian G. WalkerOrin S. Levine. (2011) During The ‘Decade Of Vaccines,’ The Lives Of 6.4 Million Children Valued At $231 Billion Could Be Saved. Health Affairs 30:6, pages 1010-1020.
Crossref
Crossref
R.A. Hajjeh, L. Privor-Dumm, K. Edmond, R. O’Loughlin, S. Shetty, U.K. Griffiths, A.P. Bear, A.L. Cohen, A. Chandran, A. Schuchat, E.K. Mulholland & M. Santosham. (2010) Supporting new vaccine introduction decisions: Lessons learned from the Hib Initiative experience. Vaccine 28:43, pages 7123-7129.
Crossref
Crossref
Orin S Levine, Maria Deloria Knoll, Andrew Jones, Damian G Walker, Nicholas Risko & Zunera Gilani. (2010) Global status of Haemophilus influenzae type b and pneumococcal conjugate vaccines: evidence, policies, and introductions. Current Opinion in Infectious Diseases 23:3, pages 236-241.
Crossref
Crossref